![](/img/cover-not-exists.png)
A bio-clinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma.
Bosch, Mark, Akhter, Ariz, Chen, Bingshu E., Mansoor, Adnan, Lebrun, David, Good, David, Crump, Michael, Shepherd, Lois, Scott, David W., Stewart, Douglas ALanguage:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2017.179309
Date:
November, 2017
File:
PDF, 2.06 MB
english, 2017